secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2025-09-16T23:59:59+00:00
Accession:  0001093557-25-000257
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

DexCom CEO Kevin Sayer takes temporary medical leave; Jacob Leach appointed interim CEO
--------------------------------------------------------------------------------

- Kevin R. Sayer, CEO and Chairman, takes temporary medical leave effective Sept 14, 2025.
- Jacob S. Leach, President and COO, appointed interim principal executive officer.
- Mark Foletta, Lead Independent Director, appointed interim chairman of the Board.
- No additional compensation for interim appointments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000257/0001093557-25-000257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000257/dxcm-20250914.htm
  HTML page:      https://secwatch.observer/filing/0001093557-25-000257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer